Resibufogenin
CAS No. 465-39-4
Resibufogenin ( RBG; Bufotenine; Resibufogenin )
Catalog No. M18571 CAS No. 465-39-4
Resibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 83 | In Stock |
|
5MG | 128 | In Stock |
|
10MG | 200 | In Stock |
|
25MG | 403 | In Stock |
|
50MG | 609 | In Stock |
|
100MG | 867 | In Stock |
|
500MG | 1737 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameResibufogenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionResibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system.
-
DescriptionResibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system. Resibufogenin corrects hypertension in a rat model of human preeclampsia, it not only prevents the advent of hypertension and proteinuria, but also the development of intrauterine growth restriction. Resibufogenina's major metabolic pathway in the human liver is CYP3A4 dominantly mediated 5β-hydroxylation .
-
SynonymsRBG; Bufotenine; Resibufogenin
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number465-39-4
-
Formula Weight384.51
-
Molecular FormulaC24H32O4
-
Purity98%
-
SolubilityDMSO : 100 mg/mL 260.07 mM;
-
SMILESCC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C6=COC(=O)C=C6)C)O
-
Chemical Name14,15beta-Epoxy-3beta-hydroxy-5beta-bufa-20,22-dienolide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CRT0273750
CRT0273750 regulates plasma LPA levels and is suitable for in vivo studies. CRT0273750 is an autotaxin (ATX) inhibitor with IC50 of 0.014 μM.
-
HT-0712
HT-0712 (IPL-455903) is a novel potent, selective PDE4 inhibitor with IC50 of 0.15 uM for PDE4D3.
-
UK-369003
UK-369003 (Gisadenafil besylate) is a novel, potent, selective, orally bioavailable PDE5 inhibitor with IC50 of 1.23 nM.